Qi Pei

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Irritable Bowel Syndrome

Endothelial Cells

Top Venues

Drug design, development and therapy

The AAPS journal

Expert opinion on drug metabolism & toxicology

Cardiovascular therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ruwei Yang, Yaqi Lin, Kaifeng Chen, Jie Huang, Shuang Yang, An Yao, Xiaoyan Yang, Deqing Lei, Jing Xiao, Guoping Yang, Qi Pei
Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling. The AAPS journal 26 (4) (2024)
Ruwei Yang, Yaqi Lin, Kaifeng Chen, Jie Huang, Shuang Yang, An Yao, Xiaoyan Yang, Deqing Lei, Jing Xiao, Guoping Yang, Qi Pei
Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling. The AAPS journal 26 (4) (2024)
Ruwei Yang, Qin Ding, Junjie Ding, Liyong Zhu, Qi Pei
Physiologically based pharmacokinetic modeling in obesity: applications and challenges. Expert opinion on drug metabolism & toxicology (2024)
Ruwei Yang, Qin Ding, Junjie Ding, Liyong Zhu, Qi Pei
Physiologically based pharmacokinetic modeling in obesity: applications and challenges. Expert opinion on drug metabolism & toxicology (2024)
Ruwei Yang, Yaqi Lin, Kaifeng Chen, Jie Huang, Shuang Yang, An Yao, Xiaoyan Yang, Deqing Lei, Jing Xiao, Guoping Yang, Qi Pei
Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling. The AAPS journal 26 (4) (2024)
Qin Ding, Shuqi Huang, Zexu Sun, Kaifeng Chen, Xin Li, Qi Pei
A Review of Population Pharmacokinetic Models of Posaconazole. Drug design, development and therapy 16 (2022)
Zeying Feng, Yaxin Liu, Yun Kuang, Shuang Yang, Jinlei Li, Ling Ye, Jie Huang, Qi Pei, Yuanyuan Huang, Guo-Ping Yang
Open-Label, Phase I, Pharmacokinetic Studies in Healthy Chinese Subjects to Evaluate the Bioequivalence and Food Effect of a Novel Formulation of Abiraterone Acetate Tablets. Drug design, development and therapy 16 (2022)
Kaifeng Chen, Ping Luo, Shaihong Zhu, Yaqi Lin, Nan Yang, Shuqi Huang, Qin Ding, Liyong Zhu, Qi Pei
Effect of Laparoscopic Sleeve Gastrectomy on the Pharmacokinetics of Oral Omeprazole Using a Population Approach. Pharmaceutics 14 (10) (2022)
Chengxiao Fu, Qi Pei, Wu Liang, Bo Yang, Wei Li, Jun Liu, Hongyi Tan, Cheng-Xian Guo, Hao Zhang, Guo-Ping Yang
Population Pharmacokinetic Modelling for Nifedipine to Evaluate the Effect of Parathyroid Hormone on CYP3A in Patients with Chronic Kidney Disease. Drug design, development and therapy 16 (2022)
Yeping Luo, Wenjing Chen, Guoping Yang, Chan Zou, Jie Huang, Yun Kuang, Kai Shen, Basheng Zhang, Shuang Yang, Hong Xiang, Zhuo Li, Qi Pei
Study on Pharmacokinetic Interactions Between HS-10234 and Emtricitabine in Healthy Subjects: An Open-Label, Two-Sequence, Self-Controlled Phase I Trial. Infectious diseases and therapy (2021)
Ya-Qian Li, Kai-Feng Chen, Jun-Jie Ding, Hong-Yi Tan, Nan Yang, Ya-Qi Lin, Cui-Fang Wu, Yue-Liang Xie, Guo-Ping Yang, Jing-Jing Liu, Qi Pei
External evaluation of published population pharmacokinetic models of polymyxin B. European journal of clinical pharmacology 77 (12) (2021)
Wenmin Song, Yu Lv, Zizhao Tang, Fangqin Nie, Panhao Huang, Qi Pei, Ren Guo
Bazedoxifene Plays a Protective Role against Inflammatory Injury of Endothelial Cells by Targeting CD40. Cardiovascular therapeutics 2020 (2020)